PhD, Co-founder, Reprogenetics & Director of The Art Institute of Washington
This presentation outlines the difficulties involved in the implementation of prospectively randomized clinical trials (RCTs) in clinical embryology procedures. The indis scriminate use of the RCT in clinical embryology is based on the narrow premise that randomization and patient concealment are sufficient to protect the study from bias. In this presentation the speaker will present evidence that this premise is often incorrect.
Jacques Cohen is the Director of The Art Institute of Washington as well as being one of the founders of Reprogenetics, an independent PGD service based in the USA and director of Tyho-Galileo Research Laboratories. He is also the Scientific Director of IVF-Online.
He was trained in the 1970s at Erasmus University in Rotterdam as a Reproductive Scientist specialized in in vitro fertilization and cryobiology. He was an embryologist at Bourn Hall Clinic, the world’s first IVF clinic directed by Robert G. Edwards and moved to the USA in 1985. He is the senior editor of Reproductive Biomedicine Online and the North-American editor of Zygote. He was the founder of Alpha – Scientists in Reproductive Medicine and one of the founders of the Preimplantation Genetics Diagnosis International Society (PGDIS). His interests are embryonic viability, cryopreservation and developing tests and tools for IVF laboratories.